Opendata, web and dolomites

CASI

AN INTEGRATED AUTOMATED ECG DIAGNOSTICS PLATFORM TO IMPROVE CARDIAC SAFETY IN CLINICAL DRUG TRIALS

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 CASI project word cloud

Explore the words cloud of the CASI project. It provides you a very rough idea of what is the project "CASI" about.

vitalograph    algorithm    solutions    70    6bn    place    market    glasgow    dual    25    segment    incorporating    cardiac    legislation    commercial    drug    focusses    successfully    world    university    customer    device    strategy    introduce    algorithms    capability    settings    reducing    pharmaceutical    whilst    3rd    party    clinical    minutes    data    cut    ago    revenue    delays    consistency    expensive    customers    purpose    manufactures    validate    certifications    designs    services    licensing    operates    entering    companies    12    validation    jurisdictions    anticipated    safety    company    poor    fits    mandated    ecg    ant    time    group    few    heavily    trials    jpal    bandwidth    ip    solution    grown    diagnostics    regulated    56m    mdd    automated    margin    skills    capacity    unnecessary    sells    fda    cfda    csa    conducting    totalling    regulatory    participated    approvals    renowned    days    ce    buying    medical    50    ten   

Project "CASI" data sheet

The following table provides information about the project.

Coordinator
VITALOGRAPH (IRELAND) LIMITED 

Organization address
address: MILL HOUSE HENRY STREET
city: LIMERICK
postcode: V94
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Ireland [IE]
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.3.1.3. (Treating and managing disease)
 Code Call H2020-SMEINST-1-2014
 Funding Scheme SME-1
 Starting year 2015
 Duration (year-month-day) from 2015-03-01   to  2015-08-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    VITALOGRAPH (IRELAND) LIMITED IE (LIMERICK) coordinator 50˙000.00

Map

 Project objective

Vitalograph is a 50 year old company, that designs, manufactures and sells medical devices in clinical settings and clinical drug trials. This proposal focusses on the validation of a new dual-purpose 12 lead ECG diagnostics device incorporating an automated algorithm to be used in the regulatory mandated cardiac safety elements of clinical drug trials. Current solutions are expensive, introduce unnecessary analysis delays and have poor data consistency. The proposed solution can cut customer costs by 50% whilst at the same time improving Vitalograph’s margin from 25% to 70% as well as reducing the analysis time from several days to a few minutes. The target market has grown to be greater than €1.6Bn in 10 years with the targeted segment being one third of this. The target customers are pharmaceutical companies conducting drug trials The project fits well with Vitalograph’s product and market strategy to develop new medical devices for clinical drug trials and will increase the available market by a factor of 10. The company already operates successfully within the market having participated in over 50 trials totalling €56m in revenue since entering the market ten years ago. It has the R&D skills and bandwidth, operational capacity and commercial capability to fully exploit the resultant offering. Vitalograph has already established a market in cardiac safety in clinical trials by buying in other devices and services. Vitalograph will work with the world-renowned Glasgow University ECG group as a 3rd party to validate their existing clinical algorithms for automated use in clinical drug trials. An IP licensing agreement is already in place and no IP issues are anticipated. The market is heavily regulated under medical device legislation in all jurisdictions (CE MDD, FDA, CSA, JPAL, CFDA etc.) but Vitalograph already has the necessary approvals, experience, regulatory knowledge and certifications to bring this product to the market.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "CASI" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "CASI" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.1.3.)

LEGACy (2019)

CeLac and European consortium for a personalized medicine approach to Gastric Cancer

Read More  

PanCareFollowUp (2019)

PanCareFollowUp: Novel, patient-centred survivorship care to improve care quality, effectiveness, cost-effectiveness and accessibility for survivors and caregivers

Read More  

INTE-AFRICA (2019)

Integrating and decentralising diabetes and hypertension services in Africa

Read More